In 2006, following an expedited review, the Food and Drug Administration approved Merck & Co.'s Gardasil vaccine, a "preventive" vaccine targeting a limited range of strains of the human papillomavirus (HPV), including two strains that are linked to the possible development of cervical cancers. In 2009, the FDA, in another "fast track" review, approved Cervarix, a similar vaccine by another pharmaceutical company, GlaxoSmithKline. In The HPV Vaccine, Mary Holland and Kim Mack Rosenberg, expert researchers on the making, marketing, and safety of vaccines, assess the quick popularity of the...
In 2006, following an expedited review, the Food and Drug Administration approved Merck & Co.'s Gardasil vaccine, a "preventive" vaccine targeting a l...
